Related Experiment Video
Updated: Dec 9, 2025

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Incidence and case fatality rate of COVID-19 in patients with inflammatory articular diseases
Natalia Mena Vázquez1, Sara Manrique-Arija2, Pablo Cabezudo-García3
1UGC de Reumatología, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, Spain.
Insights
Coronavirus disease 2019 (COVID-19) incidence and fatality rates are not elevated in patients with inflammatory articular diseases (IAD). Older age was identified as a significant risk factor for COVID-19 fatality in this population.
Area of Science:
- Rheumatology
- Infectious Diseases
- Epidemiology
Background:
- Inflammatory articular diseases (IAD) encompass conditions like rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis.
- Understanding the impact of coronavirus disease 2019 (COVID-19) on IAD patients is crucial for clinical management.
- Previous studies have not clearly defined COVID-19 outcomes in IAD populations.
Purpose of the Study:
- To determine the incidence and fatality rates of COVID-19 among patients with IAD.
- To identify specific risk factors associated with COVID-19 fatality in IAD patients.
Main Methods:
- A cross-sectional observational study comparing IAD patients with COVID-19 to matched controls.
- Cumulative incidence (CI) and case fatality rate (CFR) were primary outcomes.
- Multiple logistic regression analysis was used to identify fatality risk factors in IAD patients.
Main Results:
- No significant differences in COVID-19 CI or CFR were observed between IAD patients and controls.
- However, COVID-19 CI was higher in psoriatic arthritis and axial spondyloarthritis patients.
- Older age was the primary risk factor for fatality in IAD patients with COVID-19.
Conclusions:
- COVID-19 incidence, fatality rates, and disease characteristics do not appear to be increased in patients with IAD.
- Older age is a significant risk factor for COVID-19-related fatality in the IAD cohort.
Objective:
To describe the incidence and fatality of coronavirus disease 2019 (COVID-19) and identify risk factors to fatality in patients with inflammatory articular diseases (IAD).
Methods:
This is a cross-sectional observational study of IAD patients and COVID-19 with controls matched for age, sex, and RT-PCR. A control group was used to compare the cumulative incidence (CI) and case fatality rate (CFR). The main outcomes of the study were CI and CFR. Other variables included comorbidities, treatments, and characteristics of the COVID-19. Multiple logistic regression analysis was performed to investigate risk factors for fatality in patients with IAD.
Results:
Of the 1537 patients who fulfilled the inclusion criteria, 23/1537 (1.49%) had IAD 13 (0.8%) had rheumatoid arthritis (RA), 5 psoriatic arthritis (PsA) (0.3%) and 5 axial spondyloarthritis (0.3%). There were no significant differences in CI of COVID-19 and CFR in patients with IAD compared with COVID-19 patients without IAD. In RT-PCR positive patients, the CI of COVID-19 in PsA and AS was higher. Of the 23 IAD patients, 2 RA patients (8.6%) died. The patients did no show characteristics of the COVID-19 disease different from the population. In multivariate analysis, the factor associated with fatality in patients with IAD was older age (OR [95% CI], 1.1 [1.0-1.2]).
Conclusion:
COVID-19 CI, fatality rate and other features do not seem to be increased in IAD patients. Older age was associated with fatality in patients with IAD.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
The JAK-STAT Signaling Pathway
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease III: Medical Management
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

